DOCSLIB.ORG

ICD-10 Codes Covered Under Medical Nutritional Therapy Services

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

ICD-10 Codes covered under Medical Nutrition Therapy services – Effective February 1, 2021* ICD-10 Diagnosis Code Description ICD-10 Diagnosis Code Description A56.01 Chlamydial cystitis and urethritis E24.0 Pituitary-dependent Cushing's disease Congenital adrenogenital disorders associated B20. HIV E25.0 with enzyme deficiency B52.0 Plasmodium malariae malaria with nephropathy E20.1 Pseudohypoparathyroidism B25.1 Cytomegaloviral hepatitis E28.2 Polycystic Ovarian Syndrome B25.2 Cytomegaloviral pancreatitis E34.0 Carcinoid syndrome B52.0 Plasmodium malariae malaria with nephropathy E41 Nutritional marasmus C00.0 – C96.9 All types of Cancer code (range) E42 Marasmic kwashiorkor C96.A Histiocytic sarcoma E43 Unspecified severe protein-calorie malnutrition Other specified malignant neoplasms of C96.Z lymphoid, hematopoietic and related tissue E44.0 – E46 Moderate protein-calorie malnutrition (range) D00.00 – D09.9 Carcinoma code (range) E50 – E50.9 Vitamin A deficiency (range) D63.0 Anemia in neoplastic disease E51 – E51.9 Thiamine deficiency (range) D64.81 Anemia due to antineoplastic chemotherapy E52 Niacin deficiency [pellagra] Agranulocytosis secondary to cancer D70.1 E53.0 – E53.9 Deficiency of other B group vitamins (range) chemotherapy E54 Ascorbic acid deficiency D70.2 Other drug-induced agranulocytosis E55.0 – E55.9 Vitamin D deficiency Iron deficiency anemia secondary to blood loss D50.0 – D50.1 (range) E56.0 – E56.9 Other vitamin deficiencies D50.8 – D50.9 Other iron Deficiency Anemia (range) E58 Dietary calcium deficiency D51.0 – D51.9 B12 deficiency anemia (range) E59 Dietary selenium deficiency D52.0 – D52.9 Dietary folate anemia (range) E60 Dietary zinc deficiency D53.0 – D53.9 Other anemia (range) E61.0 – E61.9 Deficiency of other nutrient elements D55.0 – D55.9 Anemia due to enzyme disorders (range) E63.0 – E63.9 Other nutritional deficiencies D64.81 Anemia due to antineoplastic chemotherapy E64.0 – E64.9 Sequelae of protein-calorie malnutrition (range) D64.89 Other specified anemias E65 Localized adiposity D64.9 Anemia US E66.0 – E66.9 Obesity (code range) Other disorders involving the immune mechanism, D89.0-D89.2 E67.0 – E67.8 Other hyperalimentation (code range) not elsewhere classified (code range) E68 Sequelae of hyperalimentation E03.9 Hypothyroidism Disorders of aromatic amino acid metabolism/ E70.0 – E70.9 E05.90 Thyrotoxicosis PKU (code range) Disorders of branched chain amino acid E08 – E13.9 All Diabetes code range E71.0 – E71.39 metabolism (code range) E08.00 – E08.9 Diabetes due to underlying conditions (range) E71.40 – E71.43 Disorders of carnitine metabolism E09.00 – E09.9 Drug induced diabetes mellitus (range) E71.440 Ruvalcaba-Myhre-Smith syndrome E10.10 – E10.9 Type 1 Diabetes (range) E71.448 Other secondary carnitine deficiency E11.00 – E11.9 Type 2 Diabetes (range) Disorders of amino acid transport/ E72.00 – E72.9 E13.00 – E13.9 Other specified diabetes(range) homocystinuria (code range) E16.0 – E16.2 Hypoglycemia (range) E73.0 – E73.9 Lactose intolerance (code range) Other disorders of carbohydrate metabolism E20.1 Pseudohypoparathyroidism E74.00 – E74.9 (code range) E22.0 Acromegaly and pituitary gigantism *This list of diagnoses is subject to change. PRV20473-2101 ICD-10 Codes covered under Medical Nutrition Therapy services – Effective February 1, 2021* ICD-10 Diagnosis Code Description ICD-10 Diagnosis Code Description E75.21 – E75.249 Other sphingolipidosis (code range) Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex G40.201 E75.3 Sphingolipidosis, unspecified partial seizures, not intractable, with status E75.5 – E75.6 Other lipid storage disorders (code range) epilepticus Localization-related (focal) (partial) symptomatic E77.0 – E77.9 Disorders of glycoprotein metabolism (code range) epilepsy and epileptic syndromes with complex G40.209 Disorders of lipoprotein metabolism and other partial seizures, not intractable, without status E78.7 – E78.9 lipidemias (code range) epilepticus Disorders of porphyrin and bilirubin metabolism Localization-related (focal) (partial) symptomatic E80.0 – E80.29 (code range) epilepsy and epileptic syndromes with complex G40.211 partial seizures, intractable, with status E83.00 – E83.19, Disorders of mineral metabolism (code range) epilepticus E83.30 – E83.9 Localization-related (focal) (partial) symptomatic E84.0 – E84.9 Cystic fibrosis (range) epilepsy and epileptic syndromes with complex G40.219 E86.0 – E86.9 Volume depletion (code range) partial seizures, intractable, without status epilepticus Other disorders of fluid electrolyte and acid- E87.0 – E87.8 base balance (code range) Generalized idiopathic epilepsy and epileptic G40.301 – G40.309 syndromes, not intractable, with status E88.01 – E88.2, Other and unspecified metabolic disorders epilepticus (range) E88.89 (code range) E88.3 Tumor lysis syndrome Generalized idiopathic epilepsy and epileptic G40.311 – G40.319 syndromes, intractable, with status epilepticus Absence epileptic syndrome, not intractable, (range) G40.A01 – G40.A09 with status epilepticus (range) Other generalized epilepsy and epileptic Absence epileptic syndrome, intractable, with G40.A11 – G40.A19 G40.401 – G40.409 syndromes, not intractable, with status status epilepticus (range) epilepticus (range) Juvenile myoclonic epilepsy, not intractable, Other generalized epilepsy and epileptic G40.B01 – G40.B09 G40.411 with status epilepticus (range) syndromes, intractable, with status epilepticus Juvenile myoclonic epilepsy, intractable, with G40.B11 Other generalized epilepsy and epileptic status epilepticus G40.419 syndromes, intractable, without status Juvenile myoclonic epilepsy, intractable, without epilepticus G40.B19 status epilepticus Epileptic seizures related to external causes, not G40.501 Localization-related (focal) (partial) idiopathic intractable, with status epilepticus epilepsy and epileptic syndromes with seizures G40.001 Epileptic seizures related to external causes, not of localized onset, not intractable, with status G40.509 intractable, without status epilepticus epilepticus Other epilepsy, not intractable, with status Localization-related (focal) (partial) idiopathic G40.801 – G40.804 epilepticus (range) epilepsy and epileptic syndromes with seizures G40.009 Lennox-Gastaut syndrome, not intractable, with of localized onset, not intractable, without status G40.811 – G40.814 epilepticus status epilepticus Epileptic spasms, not intractable, with status Localization-related (focal) (partial) idiopathic G40.821 – G40.89 epilepsy and epileptic syndromes with seizures epilepticus (range) G40.011 – G40.019 of localized onset, intractable, with status Epilepsy, unspecified, not intractable, with status G40.901 epilepticus (range) epilepticus Localization-related (focal) (partial) symptomatic Epilepsy, unspecified, not intractable, without epilepsy and epileptic syndromes with simple G40.909 G40.101 – G40.109 status epilepticus partial seizures, not intractable, with status epilepticus (range) G40.911 – G40.919 Epilepsy Localization-related (focal) (partial) symptomatic G47.30 Sleep apnea, unspecified epilepsy and epileptic syndromes with simple G40.111 – G40.119 partial seizures, intractable, with status G47.33 Obstructive sleep apnea (adult) (pediatric) epilepticus (range) I09.81 Rheumatic heart failure I10 – I16.9 Hypertension/ HTN kidney disease/Crisis (range) PRV20473-2101 ICD-10 Codes covered under Medical Nutrition Therapy services – Effective February 1, 2021* ICD-10 Diagnosis Code Description ICD-10 Diagnosis Code Description Acute coronary thrombosis not resulting in I24.0 – I25.9 K29.80 – K29.81 Duodenitis without bleeding myocardial infarction (range) K29.90 Gastroduodenitis, unspecified, without bleeding Atherosclerotic heart disease of native coronary I25.10 artery without angina pectoris K29.91 Gastroduodenitis, unspecified, with bleeding I27.0 – I 27.2 Primary pulmonary hypertension (range) K30.0 Functional dyspepsia I27.81 Cor pulmonale (chronic) K31.0 Acute dilatation of stomach I27.82 Chronic pulmonary embolism K31.1 Adult hypertrophic pyloric stenosis I27.83 Eisenmenger's syndrome K31.2 Hourglass stricture and stenosis of stomach I27.89 Other specified pulmonary heart diseases K31.3 Pylorospasm, not elsewhere classified I27.9 Pulmonary heart disease, unspecified K31.4 Gastric diverticulum I42.2 – I43 Other hypertrophic cardiomyopathy (range) K31.5 Obstruction of duodenum I50.1 – I50.9 Heart failure (range) K31.6 Fistula of stomach and duodenum Angiodysplasia of stomach and duodenum with I51.4 Myocarditis, unspecified K31.811 – K31.9 bleeding I51.5 – I51.7 Cardiomegaly K44.0 – K44.9 Diaphragmatic hernia (range) I51.9 Heart disease, unspecified Crohn's disease of small intestine without Other heart disorders in diseases classified K50.00 I52 complications elsewhere Crohn's disease of large intestine without Other specified noninfective disorders of K50.10 I89.8 complications lymphatic vessels and lymph nodes (chylous) Crohn's disease of small intestine with rectal K50.011 – K50.019 I97.3 Postprocedural hypertension bleeding Crohn's disease of large intestine with rectal J94.0 Chylous effusion K50.111 – K50.119 bleeding Oral mucositis (ulcerative) due to antineoplastic K12.31 Crohn's disease of both small and large therapy K50.80 intestine without complications K12.33 Oral mucositis (ulcerative) due to radiation Crohn's disease of both small and large K50.811 – K50.819 K20.0 Eosinophilic esophagitis intestine with rectal bleeding Crohn's disease, unspecified,
Recommended publications
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other

    N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other

    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
  • Diseases of the Digestive System (KOO-K93)

    Diseases of the Digestive System (KOO-K93)

    CHAPTER XI Diseases of the digestive system (KOO-K93) Diseases of oral cavity, salivary glands and jaws (KOO-K14) lijell Diseases of pulp and periapical tissues 1m Dentofacial anomalies [including malocclusion] Excludes: hemifacial atrophy or hypertrophy (Q67.4) K07 .0 Major anomalies of jaw size Hyperplasia, hypoplasia: • mandibular • maxillary Macrognathism (mandibular)(maxillary) Micrognathism (mandibular)( maxillary) Excludes: acromegaly (E22.0) Robin's syndrome (087.07) K07 .1 Anomalies of jaw-cranial base relationship Asymmetry of jaw Prognathism (mandibular)( maxillary) Retrognathism (mandibular)(maxillary) K07.2 Anomalies of dental arch relationship Cross bite (anterior)(posterior) Dis to-occlusion Mesio-occlusion Midline deviation of dental arch Openbite (anterior )(posterior) Overbite (excessive): • deep • horizontal • vertical Overjet Posterior lingual occlusion of mandibular teeth 289 ICO-N A K07.3 Anomalies of tooth position Crowding Diastema Displacement of tooth or teeth Rotation Spacing, abnormal Transposition Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth K07.4 Malocclusion, unspecified K07.5 Dentofacial functional abnormalities Abnormal jaw closure Malocclusion due to: • abnormal swallowing • mouth breathing • tongue, lip or finger habits K07.6 Temporomandibular joint disorders Costen's complex or syndrome Derangement of temporomandibular joint Snapping jaw Temporomandibular joint-pain-dysfunction syndrome Excludes: current temporomandibular joint: • dislocation (S03.0) • strain (S03.4) K07.8 Other dentofacial anomalies K07.9 Dentofacial anomaly, unspecified 1m Stomatitis and related lesions K12.0 Recurrent oral aphthae Aphthous stomatitis (major)(minor) Bednar's aphthae Periadenitis mucosa necrotica recurrens Recurrent aphthous ulcer Stomatitis herpetiformis 290 DISEASES OF THE DIGESTIVE SYSTEM Diseases of oesophagus, stomach and duodenum (K20-K31) Ill Oesophagitis Abscess of oesophagus Oesophagitis: • NOS • chemical • peptic Use additional external cause code (Chapter XX), if desired, to identify cause.
  • Diagnosis One To

    Diagnosis One To

    Diagnosis One-to-One I9cm I9 Long Desc I10cm I10 Long Desc 0010 Cholera due to vibrio cholerae A000 Cholera due to Vibrio cholerae 01, biovar cholerae 0011 Cholera due to vibrio cholerae el tor A001 Cholera due to Vibrio cholerae 01, biovar eltor 0019 Cholera, unspecified A009 Cholera, unspecified 0021 Paratyphoid fever A A011 Paratyphoid fever A 0022 Paratyphoid fever B A012 Paratyphoid fever B 0023 Paratyphoid fever C A013 Paratyphoid fever C 0029 Paratyphoid fever, unspecified A014 Paratyphoid fever, unspecified 0030 Salmonella gastroenteritis A020 Salmonella enteritis 0031 Salmonella septicemia A021 Salmonella sepsis 00320 Localized salmonella infection, unspecified A0220 Localized salmonella infection, unspecified 00321 Salmonella meningitis A0221 Salmonella meningitis 00322 Salmonella pneumonia A0222 Salmonella pneumonia 00323 Salmonella arthritis A0223 Salmonella arthritis 00324 Salmonella osteomyelitis A0224 Salmonella osteomyelitis 0038 Other specified salmonella infections A028 Other specified salmonella infections 0039 Salmonella infection, unspecified A029 Salmonella infection, unspecified 0040 Shigella dysenteriae A030 Shigellosis due to Shigella dysenteriae 0041 Shigella flexneri A031 Shigellosis due to Shigella flexneri 0042 Shigella boydii A032 Shigellosis due to Shigella boydii 0043 Shigella sonnei A033 Shigellosis due to Shigella sonnei 0048 Other specified shigella infections A038 Other shigellosis 0049 Shigellosis, unspecified A039 Shigellosis, unspecified 0050 Staphylococcal food poisoning A050 Foodborne staphylococcal
  • Fy 2020 Acs Ipps

    Fy 2020 Acs Ipps

    June 24, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Attention: CMS-1716-P P.O. Box 8013 Baltimore, MD 21244-1850 RE: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2020 Rates; Proposed Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Proposed Requirements for Eligible Hospitals and Critical Access Hospitals Dear Ms. Verma: On behalf of the over 80,000 members of the American College of Surgeons (ACS), we appreciate the opportunity to submit comments to the Centers for Medicare & Medicaid Services’ (CMS) proposed rule, Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2020 Rates; Proposed Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Proposed Requirements for Eligible Hospitals and Critical Access Hospitals, published in the Federal Register on May 3, 2019. The ACS is a scientific and educational association of surgeons founded in 1913 to improve the quality of care for patients by setting high standards for surgical education and practice. Since a large portion of surgical care is provided in the inpatient hospital setting, the College has a vested interest in CMS’ Inpatient Prospective Payment System (IPPS) and related hospital quality improvement efforts, and we believe that we can offer insight to CMS’ proposed modifications to these policies for fiscal year (FY) 2020. Our comments below are presented in the order in which they appear in the proposed rule.
  • Neurodevelopmental Delay: Case Definition & Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data

    Neurodevelopmental Delay: Case Definition & Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data

    Vaccine 37 (2019) 7623–7641 Contents lists available at ScienceDirect Vaccine journal homepage: www.elsevier.com/locate/vaccine Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data Adrienne N. Villagomez a,b, Flor M. Muñoz c, Robin L. Peterson a,b, Alison M. Colbert a,b, Melissa Gladstone d, Beatriz MacDonald e, Rebecca Wilson a,b, Lee Fairlie f, Gwendolyn J. Gerner g,h, Jackie Patterson i, Nansi S. Boghossian j, Vera Joanna Burton g,h, Margarita Cortés k, Lakshmi D. Katikaneni l, Jennifer C.G. Larson m, Abigail S. Angulo a,b, Jyoti Joshi n, Mirjana Nesin o, Michael A. Padula p, ⇑ Sonali Kochhar q,r,s, Amy K. Connery a,b, , for The Brighton Collaboration Neurodevelopmental Delay Working Group 1 a University of Colorado School of Medicine, Aurora, CO, USA b Children’s Hospital of Colorado, Aurora, CO, USA c Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA d Department of Women and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK e University of New Mexico School of Medicine, Albuquerque, NM, USA f Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa g Kennedy Krieger Institute, Baltimore, MD, USA h Johns Hopkins University School of Medicine, Baltimore, MD, USA i University of North Carolina School of Medicine, Chapel Hill, NC, USA j Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia,
  • Abstracts Plenary Session: Before the First 1000 Days: Before Conception and After Birth

    Abstracts Plenary Session: Before the First 1000 Days: Before Conception and After Birth

    Abstracts Plenary Session: Before the First 1000 Days: Before Conception and After Birth INFLUENCE OF EARLY NUTRITIONAL FACTORS ON OBESITY IN THE OFFSPRING L. Moreno1 1GENUD research group- Universidad de Zaragoza- Instituto Agroalimentario de Aragón IA2 - Instituto de Investigación Sanitaria de Aragón IIS Aragón- Centro de Investigación Biomédi ca en red de Fisiopatología de la Obesidad y Nutrición CIBEROBN- Zaragoza- Spain, Facultad de Ciencias de la Salud, Zaragoza, Spain Childhood obesity is the most prevalent nutritional disorder during childhood. It develops in individuals with a genetic predisposition substrate and the presence of factors related with nutrition, sedentary behaviours and others as short sleep duration. During early periods of life, starting at conception and until the end of the second year, there is a large number of factors that could influence the development of obesity later in life: pre-pregnancy maternal body mass index (BMI), gestational weight gain, gestational diabetes, maternal malnutrition, maternal smoking during pregnancy, alcohol consumption during pregnancy, free sugars intake during pregnancy, low polyunsaturated fat (omega 3) intake during pregnancy, low physical activity levels during pregnancy, antibiotics consumption during pregnancy, high or low body weight at birth, lack of breast feeding, consumption of high protein content infant formulas, rapid infant weight gain, high protein, fat or free sugars intake during infancy, early introduction of complementary feeding and short sleep duration. From all these candidate risk factors, the ones more strongly associated with obesity development during childhood are maternal obesity before pregnancy, low birth weight and rapid weight gain during infancy. Perinatal factors also influence the expression of some genes related with obesity development.
  • Case Report a Fragment of Foley Catheter Balloon As a Cause of Bladder Stone in Woman

    Case Report a Fragment of Foley Catheter Balloon As a Cause of Bladder Stone in Woman

    Open Access Case report A fragment of Foley catheter balloon as a cause of Bladder stone in woman El Majdoub Aziz1,&, Mouad Amrani1, Khallouk Abdelhak1, Farih Moulay Hassan1 1Department of Urology, Hassan II Hospital University Center, Fez, Morocco &Corresponding author: El Majdoub Aziz, Department of Urology, Hassan II Hospital University Center, Fez, Morocco Key words: intravésical, foreign body, catheter balloon, recurrent urinary tract infections Received: 08/04/2015 - Accepted: 22/04/2015 - Published: 13/08/2015 Abstract Urinary bladder calculi are rarely seen in women and any history of previous pelvic surgery must, therefore, raise suspicion of an iatrogenic etiology. According to the literature, fewer than 2% of all bladder calculi occur in female subjects and, thus, their presence should provoke careful assessment of the etiology. We report one case of a fragment of Foley catheter balloon as a cause of Bladder stone in 28 years old woman. Weanalyzed the diagnosis, aspect and therapeutic management of this case which is the first described in literature to our knowledge. Pan African Medical Journal. 2015; 21:284 doi:10.11604/pamj.2015.21.284.6770 This article is available online at: http://www.panafrican-med-journal.com/content/article/21/284/full/ © El Majdoub Aziz et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Pan African Medical Journal – ISSN: 1937- 8688 (www.panafrican-med-journal.com) Published in partnership with the African Field Epidemiology Network (AFENET).
  • Feeding Referral Forms

    Feeding Referral Forms

    FEEDING THERAPY REFERRAL FORMS Child’s Name: ______________________________________ Date of Birth: __________________________________ Contact Name: ______________________________________ Phone No.: ____________________________________ Measurements Measurement Date Taken Weight lb oz % Height ft in % BMI Past/Existing Referrals and Specialists Referral Type Date of Referral Name of Specialist/Practice Most Recent Swallow Study Concerns First Reported Gastroenterology Dietician Otolaryngologist Pulmonologist Cardiologist Prior Feeding Therapy Additional Information: ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ Professional Therapy Services When & Where You Need Us! www.carolinatherapeutics.com ∙ [email protected] ​ ​ Tel 704.654.8599 ∙ Fax 980.938.6088 ​ ​ FEEDING REFERRAL FORMS Child’s Name: ______________________________________ Date of Birth: __________________________________ Contact Name: ______________________________________ Phone No.: ____________________________________ Commonly Used ICD-10 Codes for Feeding and Swallowing Disorders (Check all that apply) E46 Applicable to malnutrition, not otherwise specified ​ R13.10 Dysphagia, unspecified (NOS) Protein-calorie imbalance NOS F50.82 Avoidant restrictive food intake disorder R13.11 Oral phase dysphagia F84.0
  • XI. COMPLICATIONS of PREGNANCY, Childbffith and the PUERPERIUM 630 Hydatidiform Mole Trophoblastic Disease NOS Vesicular Mole Ex

    XI. COMPLICATIONS of PREGNANCY, Childbffith and the PUERPERIUM 630 Hydatidiform Mole Trophoblastic Disease NOS Vesicular Mole Ex

    XI. COMPLICATIONS OF PREGNANCY, CHILDBffiTH AND THE PUERPERIUM PREGNANCY WITH ABORTIVE OUTCOME (630-639) 630 Hydatidiform mole Trophoblastic disease NOS Vesicular mole Excludes: chorionepithelioma (181) 631 Other abnormal product of conception Blighted ovum Mole: NOS carneous fleshy Excludes: with mention of conditions in 630 (630) 632 Missed abortion Early fetal death with retention of dead fetus Retained products of conception, not following spontaneous or induced abortion or delivery Excludes: failed induced abortion (638) missed delivery (656.4) with abnormal product of conception (630, 631) 633 Ectopic pregnancy Includes: ruptured ectopic pregnancy 633.0 Abdominal pregnancy 633.1 Tubalpregnancy Fallopian pregnancy Rupture of (fallopian) tube due to pregnancy Tubal abortion 633.2 Ovarian pregnancy 633.8 Other ectopic pregnancy Pregnancy: Pregnancy: cervical intraligamentous combined mesometric cornual mural - 355- 356 TABULAR LIST 633.9 Unspecified The following fourth-digit subdivisions are for use with categories 634-638: .0 Complicated by genital tract and pelvic infection [any condition listed in 639.0] .1 Complicated by delayed or excessive haemorrhage [any condition listed in 639.1] .2 Complicated by damage to pelvic organs and tissues [any condi- tion listed in 639.2] .3 Complicated by renal failure [any condition listed in 639.3] .4 Complicated by metabolic disorder [any condition listed in 639.4] .5 Complicated by shock [any condition listed in 639.5] .6 Complicated by embolism [any condition listed in 639.6] .7 With other
  • Clinical Presentation, Management and Outcome in Diverticular Colovesical Fistulas - Our Experience

    Clinical Presentation, Management and Outcome in Diverticular Colovesical Fistulas - Our Experience

    Jemds.com Original Research Article Clinical Presentation, Management and Outcome in Diverticular Colovesical Fistulas - Our Experience Gaurav Kalra1, Rajeev Thekke Puthalath2, Suraj Hegde3, Narendra Pai4, Amit Kumar5 1Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 2Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 3Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 4Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 5Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. ABSTRACT BACKGROUND Colovesical fistula (CVF) is an abnormal communication between the urinary bladder Corresponding Author: and the large intestine, usually sigmoid colon. Diverticulitis is the most common Dr. Rajeev Thekke Puthalath, cause of CVF in most of the western studies, accounting for approximately 70% of Professor and HOD, cases. Diverticular CVF is uncommon in Asia. This case series shares the experience Department of Urology, K.S. Hegde Medical Academy, of six cases of diverticular CVF in Indian population. NITTE (Deemed to be University) Post Nithyananda Nagar, Deralakatte, METHODS Mangalore-575018, Karnataka, India. Medical records of six patients with diverticular colovesical fistulas during the period E-mail: [email protected] January 2016 - August 2019 were reviewed with regard to symptoms, diagnostic investigations, and management. Various aspects of the disease were analysed to DOI: 10.14260/jemds/2020/466 determine the common features of colovesical fistula in our population. How to Cite This Article: Kalra G, Puthalath RT, Hegde S, et al.
  • Association Between Vitamin D Level and Patients with Cholestasis

    Association Between Vitamin D Level and Patients with Cholestasis

    International Journal of Community Medicine and Public Health Anwar MM et al. Int J Community Med Public Health. 2018 May;5(5):1713-1718 http://www.ijcmph.com pISSN 2394-6032 | eISSN 2394-6040 DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20181675 Original Research Article Association between vitamin D level and patients with cholestasis Manal M. Anwar1*, Ahmed E. Arafa1, Dalia S. Morgan2, Khaled K. Mohamed3 1Department of Public Health and Community Medicine, 2Department of Pediatrics, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt 3 Department of Tropical medicine, Beni-Suef General Hospital, Beni-Suef, Egypt Received: 22 February 2018 Accepted: 21 March 2018 *Correspondence: Dr. Manal M. Anwar, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Estimate the prevalence of vitamin D deficiency among patients diagnosed with chronic cholestasis and investigates the association between their clinical manifestations and lab results of 25(OH) D levels. Methods: A cross sectional study of 50 patients aged > 3 months up to 18 years, who had medical care in the Beni- Suef University hospital, Beni-Suef governorate, Egypt. All patients were fully investigated including routine labs in addition to 25- [OH] D levels and dual energy X-ray absorptiometry (DXA). Results: Mean age was 6.5±4.5 years. Mean serum 25 (OH) D levels was 37.9±28.2; 30% of patients had 25 (OH) D <20 ng/ml and 26% had 25 (OH) D 20-<30 ng/ml.
  • The ICD-10 Classification of Mental and Behavioural Disorders

    The ICD-10 Classification of Mental and Behavioural Disorders

    The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines World Health Organization -1- Preface In the early 1960s, the Mental Health Programme of the World Health Organization (WHO) became actively engaged in a programme aiming to improve the diagnosis and classification of mental disorders. At that time, WHO convened a series of meetings to review knowledge, actively involving representatives of different disciplines, various schools of thought in psychiatry, and all parts of the world in the programme. It stimulated and conducted research on criteria for classification and for reliability of diagnosis, and produced and promulgated procedures for joint rating of videotaped interviews and other useful research methods. Numerous proposals to improve the classification of mental disorders resulted from the extensive consultation process, and these were used in drafting the Eighth Revision of the International Classification of Diseases (ICD-8). A glossary defining each category of mental disorder in ICD-8 was also developed. The programme activities also resulted in the establishment of a network of individuals and centres who continued to work on issues related to the improvement of psychiatric classification (1, 2). The 1970s saw further growth of interest in improving psychiatric classification worldwide. Expansion of international contacts, the undertaking of several international collaborative studies, and the availability of new treatments all contributed to this trend. Several national psychiatric bodies encouraged the development of specific criteria for classification in order to improve diagnostic reliability. In particular, the American Psychiatric Association developed and promulgated its Third Revision of the Diagnostic and Statistical Manual, which incorporated operational criteria into its classification system.